Condition
Biomarker Discovery and Validation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Biomarker Discovery and Validation clinical trials that are recruiting, at sites in 2 countries (most in China (1), United Kingdom (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Biomarker changes after cancer treatment in thoracic and non-thoracic cancers
This study tests circulating biomarkers like miRNAs and proteins to see how they change after cancer therapy, comparing pre-treatment baselines and two patient groups: radical RT/chemo-RT and IO-based complex systemic therapy.
-
Blood exosomal RNA test to rule out prostate cancer spread to bone
This project will try a blood-based exosomal RNA test to see if it can rule out bone metastasis in people with newly diagnosed, treatment‑naïve prostate cancer scheduled for baseline PSMA PET.
Related topics
Quick answers
How many Biomarker Discovery and Validation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.